81 FR 33679 - Office of the Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 103 (May 27, 2016)

Page Range		33679-33680
FR Document		2016-12503

Federal Register, Volume 81 Issue 103 (Friday, May 27, 2016)

[Federal Register Volume 81, Number 103 (Friday, May 27, 2016)]
[Notices]
[Pages 33679-33680]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-12503]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: June 21-22, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
review and discuss selected human gene transfer protocols and 
related data management activities. In addition, Dr. Carl June 
(Perelman School of Medicine, Univ. of Pennsylvania) will present 
the results of findings of his group regarding a rare Chimeric 
Antigen Receptor (CAR) T cell manufacturing event. For more 
information, please check the meeting agenda at the OSP Web site, 
RAC Meeting Page (available at the following URL: http://osp.od.nih.gov/office-biotechnology-activities/event/2016-06-21-120000-2016-06-210000/rac-meeting).

[[Page 33680]]

    Place: National Institutes of Health, Building 35, Conference 
Room 620/630, 9000 Rockville Pike, Rockville, MD 20852.
    Contact Person: Shayla Beckham, Extramural Support Assistant, 
Office of Science Policy, National Institutes of Health, 6705 
Rockledge Drive, Room 750, Bethesda, MD 20892-9606, 301-496-9838, 
[email protected].

    Information is also available on the Institute's/Center's home 
page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any 
additional information for the meeting will be posted when 
available.
    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: May 23, 2016.
Carolyn Baum,
Program Specialist, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-12503 Filed 5-26-16; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 103 / Friday, May 27, 2016 / Notices 33679

DEPARTMENT OF HEALTH AND U.S.C. App.), notice is hereby given of the Fishers Lane, Suite 4076, Bethesda, MD
HUMAN SERVICES meeting of the Cures Acceleration Network 20814, 301–594–4280, mckenneyk@
Review Board. mail.nih.gov.
National Institutes of Health Name of Committee: Cures Acceleration Name of Committee: National Human
Network Review Board. Genome Research Institute Special Emphasis
National Center for Advancing Date: June 13, 2016. Panel; ENCODE DATA.
Time: 12:00 p.m. to 2:00 p.m. Date: July 14, 2016.
Translational Sciences; Notice of Agenda: Report from the Institute Director.
Meetings Time: 8:00 a.m. to 5:00 p.m.
Place: National Institutes of Health,
Agenda: To review and evaluate grant
Pursuant to section 10(d) of the NCATS Board Room, 9800 Medical Center
applications.
Drive, Rockville, MD 20850, (Virtual
Federal Advisory Committee Act, as Meeting). Place: Crystal City Marriott, Need Rom
amended (5 U.S.C. App.), notice is Contact Person: Anna L. Ramsey-Ewing, Room, 1999 Jefferson Davis Highway,
hereby given of the meeting of the Ph.D., Executive Secretary, National Center Arlington, VA 22202.
National Center for Advancing for Advancing Translational Sciences, 1 Contact Person: Lita Proctor, Ph.D.,
Translational Sciences Advisory Democracy Plaza, Room 1072, Bethesda, MD Extramural Research Programs Staff, Program
20892, 301–435–0809, anna.ramseyewing@ Director, Human Microbiome Project,
Council.
nih.gov. National Human Genome Research Institute,
The meeting will be open as indicated
This notice is being published less than 15 5635 Fishers Lane, Suite 4076, Bethesda, MD
below, viewing virtually by Webex. 20892, 301 496–4550, proctorlm@
The meeting will be closed to the days prior to the meeting due to finalizing
the agenda and scheduling of meeting topics. mail.nih.gov.
public in accordance with the
(Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance
provisions set forth in sections Program Nos. 93.172, Human Genome
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry Research, National Institutes of Health, HHS)
as amended. The grant applications and Research; 93.350, B—Cooperative Dated: May 20, 2016.
the discussions could disclose Agreements; 93.859, Biomedical Research
confidential trade secrets or commercial Sylvia L. Neal,
and Research Training, National Institutes of
property such as patentable material, Health, HHS) Program Analyst, Office of Federal Advisory
and personal information concerning Committee Policy.
Dated: May 23, 2016.
individuals associated with the grant [FR Doc. 2016–12501 Filed 5–26–16; 8:45 am]
David Clary,
applications, the disclosure of which BILLING CODE 4140–01–P
Program Analyst, Office of Federal Advisory
would constitute a clearly unwarranted Committee Policy.
invasion of personal privacy
[FR Doc. 2016–12500 Filed 5–26–16; 8:45 am] DEPARTMENT OF HEALTH AND
Individuals can register to view and
BILLING CODE 4140–01–P HUMAN SERVICES
access the meeting by the link below.
https://nih.webex.com/nih/onstage/
g.php?MTID=ea58bf69ded National Institutes of Health
DEPARTMENT OF HEALTH AND
4e3ef172feeb063ee9e4e5. HUMAN SERVICES
1. Go to ‘‘Event Status’’ on the left Office of the Director, National
hand side of page, then click ‘‘Register’’. Institutes of Health; Notice of Meeting
National Institutes of Health
On the registration form, enter your
Pursuant to section 10(a) of the
information and then click ‘‘Submit’’ to National Human Genome Research Federal Advisory Committee Act, as
complete the required registration. Institute; Notice of Closed Meetings
2. You will receive a personalized amended (5 U.S.C. App.), notice is
email with the live event link. Pursuant to section 10(d) of the hereby given of a meeting of the
Federal Advisory Committee Act, as Recombinant DNA Advisory Committee.
Name of Committee: National Center for amended (5 U.S.C. App.), notice is
Advancing Translational Sciences Advisory The meeting will be open to the
Council.
hereby given of the following meetings. public, with attendance limited to space
Date: June 13, 2016.
The meetings will be closed to the available. Individuals who plan to
Open: 12:00 p.m. to 2:00 p.m. public in accordance with the attend and need special assistance, such
Agenda: Report from the Institute Director provisions set forth in sections as sign language interpretation or other
and other staff. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., reasonable accommodations, should
Place: National Institutes of Health, as amended. The grant applications and notify the Contact Person listed below
NCATS Board Room, 9800 Medical Center the discussions could disclose
Drive, Rockville, MD 20850, (Virtual
in advance of the meeting.
confidential trade secrets or commercial
Meeting). property such as patentable material, Name of Committee: Recombinant DNA
Closed: 2:00 p.m. to 3:00 p.m. and personal information concerning Advisory Committee.
Agenda: To review and evaluate grant Date: June 21–22, 2016.
applications.
individuals associated with the grant
Time: 8:00 a.m. to 5:00 p.m.
Place: National Institutes of Health, applications, the disclosure of which Agenda: The NIH Recombinant DNA
NCATS Board Room, 9800 Medical Center would constitute a clearly unwarranted Advisory Committee (RAC) will review and
Drive, Rockville, MD 20850, (Virtual invasion of personal privacy. discuss selected human gene transfer
Meeting). Name of Committee: National Human protocols and related data management
Contact Person: Anna L. Ramsey-Ewing, Genome Research Institute Special Emphasis activities. In addition, Dr. Carl June
Ph.D., Executive Secretary, National Center Panel; ENCODE Characterization. (Perelman School of Medicine, Univ. of
for Advancing Translational Sciences, 1 Date: July 7, 2016. Pennsylvania) will present the results of
sradovich on DSK3TPTVN1PROD with NOTICES

Democracy Plaza, Room 1072, Bethesda, MD Time: 8:00 a.m. to 5:00 p.m. findings of his group regarding a rare
20892, 301–435–0809, anna.ramseyewing@ Agenda: To review and evaluate grant Chimeric Antigen Receptor (CAR) T cell
nih.gov. applications. manufacturing event. For more information,
This notice is being published less than 15 Place: Renaissance Arlington Capital View please check the meeting agenda at the OSP
days prior to the meeting due to finalizing Hotel, 2800, Studio D, South Potomac Ave., Web site, RAC Meeting Page (available at the
the agenda and scheduling of meeting topics. Arlington, VA 22202. following URL: http://osp.od.nih.gov/office-
Pursuant to section 10(a) of the Federal Contact Person: Keith McKenney, Ph.D., biotechnology-activities/event/2016-06-21-
Advisory Committee Act, as amended (5 Scientific Review Officer, NHGRI, 5635 120000-2016-06-210000/rac-meeting).

VerDate Sep<11>2014 18:00 May 26, 2016 Jkt 238001 PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 E:\FR\FM\27MYN1.SGM 27MYN1

Document Created: 2018-02-07 15:09:39
Document Modified: 2018-02-07 15:09:39

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 21-22, 2016.
FR Citation		81 FR 33679

81 FR 33679 - Office of the Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 103 (May 27, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health